3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Small Cell Lung Carcinoma
3
Neoplasm Metastasis
3
Wilms Tumor
2
Sarcoma
2
Retinoblastoma
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Lymphoma
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Burkitt Lymphoma
2
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Germ Cell and Embryonal
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Interventions
Cyclophosphamide
3
fludarabine
2
Vorinostat
2
Sirolimus
2
Mesna
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Busulfan
2
sodium thiosulfate
1
ripretinib
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
etoposide phosphate
1
copper dotatate CU-64
1
Ursodeoxycholic Acid
1
Topotecan
1
Thrombopoietin
1
Thiotepa
1
Therapeutics
1
Sunitinib
1
Stem Cell Transplantation
1
Simvastatin
1
Radiotherapy, Image-Guided
1
Radiation
1
Psychiatric Rehabilitation
1
Plicamycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Topotecan
×
Gastrointestinal
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled